1 Min Read
May 18 (Reuters) - Acorda Therapeutics Inc
* Acorda Therapeutics - plans to file a new drug application for inbrija with U.S. FDA by end of Q2 of 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.